Akoya Biosciences Inc (NASDAQ:AKYA) — Market Cap & Net Worth
Market Cap & Net Worth: Akoya Biosciences Inc (AKYA)
Akoya Biosciences Inc (NASDAQ:AKYA) has a market capitalization of $64.44 Million ($64.44 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20896 globally and #4479 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Akoya Biosciences Inc's stock price $1.29 by its total outstanding shares 49954200 (49.95 Million). Analyse Akoya Biosciences Inc (AKYA) cash conversion ratio to see how efficiently the company converts income to cash.
Akoya Biosciences Inc Market Cap History: 2021 to 2025
Akoya Biosciences Inc's market capitalization history from 2021 to 2025. Data shows change from $764.80 Million to $64.44 Million (-50.68% CAGR).
Index Memberships
Akoya Biosciences Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.00% | #600 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #2018 of 3165 |
Weight: Akoya Biosciences Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Akoya Biosciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Akoya Biosciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.40x
Akoya Biosciences Inc's market cap is 1.40 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $764.80 Million | $54.92 Million | -$42.94 Million | 13.93x | N/A |
| 2022 | $478.06 Million | $74.86 Million | -$70.64 Million | 6.39x | N/A |
| 2023 | $243.78 Million | $96.63 Million | -$63.32 Million | 2.52x | N/A |
| 2024 | $114.40 Million | $81.67 Million | -$55.37 Million | 1.40x | N/A |
Competitor Companies of AKYA by Market Capitalization
Companies near Akoya Biosciences Inc in the global market cap rankings as of May 4, 2026.
Key companies related to Akoya Biosciences Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #136 globally with a market cap of $162.57 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #250 globally with a market cap of $98.12 Billion USD ( €83.93 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #274 globally with a market cap of $93.24 Billion USD ( €79.76 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #523 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #136 | Intuitive Surgical Inc | NASDAQ:ISRG | $162.57 Billion | $457.78 |
| #250 | EssilorLuxottica S. A. | PA:EL | $98.12 Billion | €181.25 |
| #274 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $93.24 Billion | €88.50 |
| #523 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Akoya Biosciences Inc Historical Marketcap From 2021 to 2025
Between 2021 and today, Akoya Biosciences Inc's market cap moved from $764.80 Million to $ 64.44 Million, with a yearly change of -50.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $64.44 Million | -43.67% |
| 2024 | $114.40 Million | -53.07% |
| 2023 | $243.78 Million | -49.01% |
| 2022 | $478.06 Million | -37.49% |
| 2021 | $764.80 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Akoya Biosciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $64.44 Million USD |
| MoneyControl | $64.44 Million USD |
| MarketWatch | $64.44 Million USD |
| marketcap.company | $64.44 Million USD |
| Reuters | $64.44 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Akoya Biosciences Inc
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImag… Read more